167 related articles for article (PubMed ID: 26331965)
1. CCL20-CCR6 Cytokine Network Facilitate Treg Activity in Advanced Grades and Metastatic Variants of Hepatocellular Carcinoma.
Li WM; Liu HR
Scand J Immunol; 2016 Jan; 83(1):33-7. PubMed ID: 26331965
[TBL] [Abstract][Full Text] [Related]
2. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.
Chen KJ; Lin SZ; Zhou L; Xie HY; Zhou WH; Taki-Eldin A; Zheng SS
PLoS One; 2011; 6(9):e24671. PubMed ID: 21935436
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma.
Rubie C; Frick VO; Wagner M; Rau B; Weber C; Kruse B; Kempf K; Tilton B; König J; Schilling M
Scand J Immunol; 2006 Jun; 63(6):468-77. PubMed ID: 16764701
[TBL] [Abstract][Full Text] [Related]
5. High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma.
Chen B; Zhang D; Zhou J; Li Q; Zhou L; Li SM; Zhu L; Chou KY; Zhou L; Tao L; Lu LM
Oncol Rep; 2013 Sep; 30(3):1380-90. PubMed ID: 23835793
[TBL] [Abstract][Full Text] [Related]
6. Regulation of CD4⁺FOXP3⁺ T cells by CCL20/CCR6 axis in early unexplained recurrent miscarriage patients.
Zhang XX; Kang XM; Zhao AM
Genet Mol Res; 2015 Aug; 14(3):9145-54. PubMed ID: 26345847
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients.
Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Cai XY; He HW; Jin JJ; Cheng YF; Fan J; Sun J; Qiu SJ
J Gastroenterol Hepatol; 2013 Sep; 28(9):1555-64. PubMed ID: 23517245
[TBL] [Abstract][Full Text] [Related]
8. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
[TBL] [Abstract][Full Text] [Related]
9. A tumour-promoting role of Th9 cells in hepatocellular carcinoma through CCL20 and STAT3 pathways.
Tan H; Wang S; Zhao L
Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):213-221. PubMed ID: 27797409
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma].
Chang X; Wang L; Zang M; Rong W; Wu Z; Liu L; Du J; Liu J; Wu J; Qu C
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):5-10. PubMed ID: 25877311
[TBL] [Abstract][Full Text] [Related]
11. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.
Rubie C; Frick VO; Wagner M; Weber C; Kruse B; Kempf K; König J; Rau B; Schilling M
World J Gastroenterol; 2006 Nov; 12(41):6627-33. PubMed ID: 17075975
[TBL] [Abstract][Full Text] [Related]
12. Treg-specific demethylated region activity in isolated regulatory t lymphocytes is a surrogate for disease severity in hepatocellular carcinoma.
Liu HR; Li WM
IUBMB Life; 2015 May; 67(5):355-60. PubMed ID: 25907075
[TBL] [Abstract][Full Text] [Related]
13. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
[TBL] [Abstract][Full Text] [Related]
14. Amphiregulin activates regulatory T lymphocytes and suppresses CD8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells.
Yuan CH; Sun XM; Zhu CL; Liu SP; Wu L; Chen H; Feng MH; Wu K; Wang FB
Oncotarget; 2015 Oct; 6(31):32138-53. PubMed ID: 26451607
[TBL] [Abstract][Full Text] [Related]
15. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis.
Rubie C; Oliveira V; Kempf K; Wagner M; Tilton B; Rau B; Kruse B; Konig J; Schilling M
Tumour Biol; 2006; 27(3):166-74. PubMed ID: 16641550
[TBL] [Abstract][Full Text] [Related]
16. Enrichment of Human CCR6
Lee JJ; Kao KC; Chiu YL; Jung CJ; Liu CJ; Cheng SJ; Chang YL; Ko JY; Chia JS
J Immunol; 2017 Jul; 199(2):467-476. PubMed ID: 28600287
[TBL] [Abstract][Full Text] [Related]
17. Eomes promotes esophageal carcinoma progression by recruiting Treg cells through the CCL20-CCR6 pathway.
Lian J; Liu S; Yue Y; Yang Q; Zhang Z; Yang S; Zhang Y
Cancer Sci; 2021 Jan; 112(1):144-154. PubMed ID: 33113266
[TBL] [Abstract][Full Text] [Related]
18. Foxp3+ regulatory T cells are associated with the natural history of chronic hepatitis B and poor prognosis of hepatocellular carcinoma.
Wang F; Jing X; Li G; Wang T; Yang B; Zhu Z; Gao Y; Zhang Q; Yang Y; Wang Y; Wang P; Du Z
Liver Int; 2012 Apr; 32(4):644-55. PubMed ID: 22118340
[TBL] [Abstract][Full Text] [Related]
19. The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients.
Zhang CY; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
Biomed Pharmacother; 2015 Feb; 69():242-8. PubMed ID: 25661365
[TBL] [Abstract][Full Text] [Related]
20. An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease.
Comerford I; Bunting M; Fenix K; Haylock-Jacobs S; Litchfield W; Harata-Lee Y; Turvey M; Brazzatti J; Gregor C; Nguyen P; Kara E; McColl SR
Bioessays; 2010 Dec; 32(12):1067-76. PubMed ID: 20954179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
